DALLAS, Feb. 19, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring DARA BioSciences Inc. (Nasdaq:DARA). The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
The full report is available at: http://www.stockpreacher.com/n/DARA
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher
DARA BioSciences Inc. (DARA), formerly Point Therapeutics Inc., is a development stage pharmaceutical company that acquires therapeutic molecules and medical technologies from third parties, and advances their clinical development for later sale to pharmaceutical and biotechnology companies. DARA focuses on two drug development programs: KRN5500 for neuropathic pain in cancer patients and DB959 for type 2 diabetes. On February 12, 2008, Point Therapeutics and DARA BioSciences completed their merger transaction, in which DP Acquisition Corp. (a wholly owned subsidiary of Point) merged with and into DARA BioSciences Inc.
Message Board Search for DARA: http://www.boardcentral.com/boards/DARA
In the report, the analyst notes:
"The Company has two drug candidates with cleared IND's (Investigational New Drug) applications from the FDA. One of the candidates, KRN55000, has completed a phase IIa clinical trial for cancer patients with neuropathic pain.
"DARA efficiently advances product candidates through clinical development, yielding commercially and medically attractive therapeutics. The Company's strategy exploits the need of midsize and large pharmaceutical companies to fill their sparse pipelines. The development and liquidity strategy for each entity varies according to market conditions, stage of development, and competitive market landscape."
To read the entire report visit: http://www.stockpreacher.com/n/DARA
See what investors are saying about DARA at penny stock forum
StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com
StockPreacher.com Disclosure
StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. StockPreacher.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.